Proximal Ventures raises debut fund to back startups bringing AI to drug development
Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma
By TechCrunch
Excerpt shared by Lazyfounder

While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn’t stop Sahir Raoof, a former SignalFire investor and executive at two healthcare startups, from raising $27.5 million for his first solo VC fund.
Raoof’s firm, Proximal Ventures, is betting that AI can transform the tools, infrastructure, and services that support drug development.
Courtesy
This story was originally published by TechCrunch. All rights belong to the original publisher.
Read the original on techcrunch.com ↗
